Form 4: AtriCure Director B. Kristine Johnson Reports Acquisition of Shares Through Restricted Stock Award

Director B. Kristine Johnson reports acquiring 5,401 shares of AtriCure, Inc. through a restricted stock award that vests in one year.

Summary

• B. Kristine Johnson, a director of AtriCure, Inc., filed a Form 4 to report changes in beneficial ownership.
• On May 19, 2025, Johnson acquired 5,401 shares of AtriCure common stock through a restricted stock award under the company's 2023 Stock Incentive Plan.
• The shares were acquired at a price of $0.
• These shares will vest on the one-year anniversary of the grant date.
• Following the transaction, Johnson's total beneficial ownership of AtriCure common stock is 49,810 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of a stock award, which is neither particularly positive nor negative on its own.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The restricted stock award vests in one year, suggesting a commitment from the director to the company's long-term performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions, allowing investors to monitor the actions of company insiders.

Key Dates

Keywords

AtriCure, Director, Form 4, Beneficial Ownership, Restricted Stock Award, Stock Incentive Plan, ATRC